These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2567040)

  • 21. Serotonin and dopamine systems regulating alcohol intake.
    McBride WJ; Murphy JM; Gatto GJ; Levy AD; Lumeng L; Li TK
    Alcohol Alcohol Suppl; 1991; 1():411-6. PubMed ID: 1726986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin receptor subtypes: implications for psychopharmacology.
    Cowen PJ
    Br J Psychiatry Suppl; 1991 Sep; (12):7-14. PubMed ID: 1840764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychopharmacology of anxiety disorders: on the role of serotonin in the treatment of anxiety states and phobic disorders.
    Westenberg HG; den Boer JA; Kahn RS
    Psychopharmacol Bull; 1987; 23(1):145-9. PubMed ID: 3110855
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunocytochemical study of the forebrain serotonergic innervation in Sardinian alcohol-preferring rats.
    Casu MA; Pisu C; Lobina C; Pani L
    Psychopharmacology (Berl); 2004 Mar; 172(3):341-51. PubMed ID: 14634717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence.
    Pettinati HM
    Alcohol Clin Exp Res; 1996 Oct; 20(7 Suppl):23A-29A. PubMed ID: 8904991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidepressants and serotonin neurons of the raphe.
    Constantinidis J; Dick P; Tissot R
    Neuropsychobiology; 1981; 7(3):113-21. PubMed ID: 6785659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The status of serotonin-selective pharmacotherapy in the treatment of alcohol dependence.
    Pettinati HM; Kranzler HR; Madaras J
    Recent Dev Alcohol; 2003; 16():247-62. PubMed ID: 12638641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
    Stahl SM
    J Clin Psychiatry; 1997; 58 Suppl 8():20-6. PubMed ID: 9236732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zimeldine: a review of its effects on ethanol consumption.
    Amit Z; Sutherland EA; Gill K; Ogren SO
    Neurosci Biobehav Rev; 1984; 8(1):35-54. PubMed ID: 6328388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonin-1A anxiolytics: an overview.
    Feighner JP; Boyer WF
    Psychopathology; 1989; 22 Suppl 1():21-6. PubMed ID: 2567039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tryptophan and 5-hydroxytryptamine metabolism in alcoholism.
    Badawy AA; Morgan CJ; Thomas R
    Alcohol Alcohol Suppl; 1993; 2():231-5. PubMed ID: 7748305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azapirones: history of development.
    Eison AS
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):2S-5S. PubMed ID: 1973936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic serotonin deficiency and alcohol preference in the fawn hooded rats.
    Rezvani AH; Overstreet DH; Janowsky DS
    Alcohol Alcohol; 1990; 25(5):573-5. PubMed ID: 2088356
    [No Abstract]   [Full Text] [Related]  

  • 34. Cannabinoid-serotonin interactions in alcohol-preferring vs. alcohol-avoiding mice.
    Kelaï S; Hanoun N; Aufrère G; Beaugé F; Hamon M; Lanfumey L
    J Neurochem; 2006 Oct; 99(1):308-20. PubMed ID: 16987253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the selective 5-hydroxytryptamine uptake inhibitors paroxetine and zimeldine on EEG sleep and waking stages in the rat.
    Kleinlogel H; Burki HR
    Neuropsychobiology; 1987; 17(4):206-12. PubMed ID: 2964564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six-month open trial with Zimelidine in alcohol-dependent patients: reduction in days of alcohol intake.
    Balldin J; Berggren U; Bokström K; Eriksson M; Gottfries CG; Karlsson I; Wålinder J
    Drug Alcohol Depend; 1994 Jun; 35(3):245-8. PubMed ID: 7956755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiolytics and the alcoholic patient.
    Meyer RE
    J Stud Alcohol; 1986 Jul; 47(4):269-73. PubMed ID: 2875216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of buspirone and its metabolite 1-pyrimidinylpiperazine in the remission of comorbid anxiety with depressive features and alcohol dependency.
    Tollefson GD; Lancaster SP; Montague-Clouse J
    Psychopharmacol Bull; 1991; 27(2):163-70. PubMed ID: 1924664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic effects of serotonin uptake inhibitors in depression.
    Asberg M; Eriksson B; Mårtensson B; Träskman-Bendz L; Wägner A
    J Clin Psychiatry; 1986 Apr; 47 Suppl():23-35. PubMed ID: 2937776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.